TG Therapeutics, Inc. (TGTX)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 03:17PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 2.69B |
| Enterprise value | 2.59B |
| Trailing P/E | 58.07 |
| Forward P/E | 72.46 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 9.03 |
| Price/book (mrq) | 16.81 |
| Enterprise value/revenue | 8.97 |
| Enterprise value/EBITDA | 47.98 |
Trading information
Stock price history
| Beta (5Y monthly) | 2.33 |
| 52-week change 3 | -41.84% |
| S&P500 52-week change 3 | 26.36% |
| 52-week high 3 | 30.84 |
| 52-week low 3 | 6.46 |
| 50-day moving average 3 | 15.35 |
| 200-day moving average 3 | 13.23 |
Share statistics
| Avg vol (3-month) 3 | 3.76M |
| Avg vol (10-day) 3 | 3.58M |
| Shares outstanding 5 | 154.54M |
| Implied shares outstanding 6 | 154.54M |
| Float 8 | 133.25M |
| % held by insiders 1 | 9.55% |
| % held by institutions 1 | 59.26% |
| Shares short (30 Apr 2024) 4 | 37.85M |
| Short ratio (30 Apr 2024) 4 | 13.35 |
| Short % of float (30 Apr 2024) 4 | 27.08% |
| Short % of shares outstanding (30 Apr 2024) 4 | 24.49% |
| Shares short (prior month 28 Mar 2024) 4 | 34.36M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 100:5625 |
| Last split date 3 | 30 Apr 2012 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 14.24% |
| Operating margin (ttm) | -14.60% |
Management effectiveness
| Return on assets (ttm) | 10.59% |
| Return on equity (ttm) | 43.93% |
Income statement
| Revenue (ttm) | 289.33M |
| Revenue per share (ttm) | 2.02 |
| Quarterly revenue growth (yoy) | 713.50% |
| Gross profit (ttm) | N/A |
| EBITDA | 48.53M |
| Net income avi to common (ttm) | 41.2M |
| Diluted EPS (ttm) | 0.30 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 209.78M |
| Total cash per share (mrq) | 1.47 |
| Total debt (mrq) | 111.99M |
| Total debt/equity (mrq) | 69.95% |
| Current ratio (mrq) | 3.62 |
| Book value per share (mrq) | 1.12 |
Cash flow statement
| Operating cash flow (ttm) | 20.28M |
| Levered free cash flow (ttm) | -2.9M |
© 2024 Yahoo. All rights reserved.